UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000018365
Receipt No. R000021266
Official scientific title of the study Safety and efficacy of ganglionated plexus ablation in the hemodialysis patients undergoing pulmonary vein isolation for paroxysmal atrial fibrillation
Date of disclosure of the study information 2015/07/21
Last modified on 2018/06/22 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Safety and efficacy of ganglionated plexus ablation in the hemodialysis patients undergoing pulmonary vein isolation for paroxysmal atrial fibrillation
Title of the study (Brief title) Safety and efficacy of ganglionated plexus ablation in the hemodialysis patients undergoing pulmonary vein isolation for paroxysmal atrial fibrillation
Region
Japan

Condition
Condition Paroxysmal atrial fibrillation
Renal disease
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the maintenance of sinus rhythm after ganglionated plexus ablation in the end-stage renal disease patients undergoing pulmonary vein isolation for paroxysmal atrial fibrillation
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Recurrence within one year from the first ablation
Key secondary outcomes i) Recurrence within one year from the last ablation
ii) Procedure time, fluoroscopic time, complications
iii) Pulmonary congestion necessary to extend hospital stay
iv) Increase in weight after ablation
v) Unscheduled hemodialysis
vi) Cerebral infarction, systemic thromboembolism
vii) All-cause death, cardiac death, sudden death

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Treatment of ganglionated plexus ablation and pulmonary vein isolation before catheter ablation
Interventions/Control_2 Treatment of pulmonary vein isolation before catheter ablation
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria a. Hemodialysis patients who is planning to receive treatment of first catheter ablation for paroxysmal atrial fibrillation
b. Patients who received sufficient explanation, understood it and gave written consent based on their free will, before participating in this study
Key exclusion criteria a. Patients with non-valvular atrial fibrillation, after open heart surgery
b. NYHA III or IV
c. Peritoneal dialysis patients
d. Patients who were judged inappropriate by the principal investigator
Target sample size 200

Research contact person
Name of lead principal investigator Yoshio Furukawa
Organization Osaka General Medical Center
Division name Department of Cardiology
Address 3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka
TEL 06-6692-1201
Email kenkyusien@gh.opho.jp

Public contact
Name of contact person Yoshio Furukawa
Organization Osaka General Medical Center
Division name Department of Cardiology
Address 3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka
TEL 06-6692-1201
Homepage URL
Email kenkyusien@gh.opho.jp

Sponsor
Institute Osaka General Medical Center
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor Hyogo College of Medicine
Osaka Rosai Hospital
Kansai Rosai Hospital
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 大阪府立急性期・総合医療センター(大阪府)

Other administrative information
Date of disclosure of the study information
2015 Year 07 Month 21 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 01 Month 13 Day
Anticipated trial start date
2015 Year 03 Month 11 Day
Last follow-up date
2019 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 07 Month 21 Day
Last modified on
2018 Year 06 Month 22 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021266